ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,309, issued on Sept. 23, was assigned to KOREA ATOMIC ENERGY RESEARCH INSTITUTE (Daejeon, South Korea).
"Anti-TM4SF4 antibody and uses thereof" was invented by In Gyu Kim (Daejeon, South Korea), Rae Kwon Kim (Sejong, South Korea), Jai Ha Lee (Daejeon, South Korea), Chang Kyu Heo (Daejeon, South Korea), Yeon Jee Kahm (Hwaseong-si, South Korea), Byung Chul Shin (Seoul, South Korea), Eun Wie Cho (Daejeon, South Korea), Chun Jeih Ryu (Seoul, South Korea), Min Kyu Kim (Seoul, South Korea) and Mun Ju Choi (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel antibodies or antigen-binding fragments there...